Suspension of Italian medtech price cuts upheld

05/14/2013 | Clinica

An Italian court ruling has upheld the suspension of a government mandate to cut prices for medical devices, invalidating the program that was scheduled to go into effect in January. The court found that the price cuts were based on a faulty use of the national medical device classification system and used inaccurate price sampling. Italian health care authorities must now come up with a different formula for implementing cost controls that recognizes the varied and specialized characteristics of the medtech sector.

View Full Article in:

Clinica

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT